Mrv1718009111815022D 24 24 0 0 0 0 999 V2000 2.8463 1.7054 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.4265 2.4146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2467 2.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8560 0.8804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1468 0.4655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1468 -0.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8608 -0.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1420 -2.0044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8608 -1.5896 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.5699 0.4800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5699 -0.3642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8560 -1.5992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1420 -2.8294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4279 -0.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5699 -2.0044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4328 -1.5896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7078 2.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7078 2.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1420 -0.3545 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -2.8608 -0.7646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7140 -0.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4328 -0.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7140 -0.3545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 1 0 0 0 0 1 4 1 6 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 7 6 1 0 0 0 0 8 9 1 0 0 0 0 9 20 1 1 0 0 0 10 4 2 0 0 0 0 11 7 1 0 0 0 0 12 7 2 0 0 0 0 13 8 2 0 0 0 0 14 6 2 0 0 0 0 15 9 1 0 0 0 0 16 8 1 0 0 0 0 17 2 1 0 0 0 0 18 2 1 0 0 0 0 19 22 1 0 0 0 0 20 19 1 0 0 0 0 21 14 1 0 0 0 0 22 24 1 0 0 0 0 23 21 1 0 0 0 0 24 23 1 0 0 0 0 3 2 1 0 0 0 0 M END > DB01597 > drugbank > CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O > InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1 > DHSUYTOATWAVLW-WFVMDLQDSA-N > C16H26N2O5S > 358.453 > 358.156242642 > 6 > 50 > 38.28482513768614 > 1 > 4 > 0 > 0 > (2Z)-7-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-2-{[(1S)-2,2-dimethylcyclopropyl]formamido}hept-2-enoic acid > -0.29 > -1.2655645198615506 > -3.55 > 0 > 1 > -1 > 4.188113909835283 > 2.5284803772377016 > 9.142241141228936 > 129.72 > 92.85069999999999 > 11 > 1 > 1.00e-01 g/l > cilastatin > 0 > DB01597 > EXPT00918 > approved; investigational > Cilastatin > (L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid; (Z)-(S)-6-carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine; (Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid; Cilastatin; Cilastatina; Cilastatine; Cilastatinum > Cilastatin Sodium Sterile; Imipenem and Cilastatin; Imipenem and Cilastatin for Injection; Imipenem and Cilastatin for Injection USP; Imipenem and Cilastatin for Injection, USP; Primaxin; Primaxin 250; Primaxin 500; Primaxin IV; Primaxin IV 250/250 Add-vantage Vial; Primaxin IV 500; Primaxin Im; Recarbrio; Taro-imipenem-cilastatin > Cilastatin sodium $$$$